Skip to main content

Department of Medicine Archives

NIH-funded trial to determine if immunomodulation can improve brain and cardiovascular dysfunction in Long COVID

Feb. 22, 2024—Vanderbilt University Medical Center is working with scientists around the U.S. to launch the first Phase III, multicenter, placebo-controlled trial to determine the effect of immunomodulation on Long COVID.

Read more

VUMC mourns loss of renowned pulmonary medicine physician-scientist John H. Newman

Feb. 22, 2024—John H. Newman, MD, an acclaimed physician-scientist in Vanderbilt University Medical Center’s Division of Allergy, Pulmonary and Critical Care Medicine who made numerous contributions to the knowledge of pulmonary vascular disease, died on Tuesday, Feb. 20, after a several-month illness. He was 78.

Read more

Large, diverse genetic study of glaucoma implicates vascular and cancer-related genes

Feb. 21, 2024—An international genetic study using multiancestry biobanks has identified novel genetic locations associated with primary open-angle glaucoma, the most common type of glaucoma and the leading cause of irreversible blindness globally.

Read more

System offers new option to treat mitral regurgitation

Feb. 20, 2024—In a novel procedure, the Vanderbilt Heart & Vascular Institute (VHVI) successfully performed the first large-flange Innovalve transcatheter mitral valve replacement.

Read more

Liver disease specialist Spann receives two career development awards

Feb. 20, 2024—Vanderbilt's Ashley Spann, MD, MSACI, is the inaugural recipient of the Harold Amos Medical Faculty Development Program Hepatology Award from the American Association for the Study of Liver Diseases.

Read more

VUMC part of major step to achieving precision medicine

Feb. 19, 2024—An analysis of genomic data from nearly 250,000 participants in the National Institutes of Health’s All of Us Research Program has identified more than 275 million previously unreported genetic variations, nearly 4 million of which have potential health consequences.

Read more

Timothy Blackwell to chair the Department of Internal Medicine at the University of Michigan

Feb. 15, 2024—Timothy Blackwell, MD, director of the Division of Allergy, Pulmonary and Critical Care Medicine, is leaving Vanderbilt University Medical Center to chair the Department of Internal Medicine at the University of Michigan.

Read more

Hartmann, Kripalani honored at Translational Research Forum

Feb. 15, 2024—Katherine Hartmann, MD, PhD, and Sunil Kripalani, MD, MSc, were honored for their service to translational scientists at Vanderbilt University Medical Center during the Vanderbilt Translational Research Forum.

Read more

VUMC study finds molecular switch key to repair of kidney damage

Feb. 7, 2024—Researchers at Vanderbilt University Medical Center have identified Rac1, a molecular switch that regulates the actin cytoskeleton of epithelial cells in the collecting ducts, as a driver of post-obstructive kidney repair.

Read more

Study links small pancreas size to faster progression to stage 3 Type 1 diabetes

Feb. 2, 2024—A multicenter, longitudinal study, co-led by investigators at the Vanderbilt Diabetes Research and Training Center, has discovered that a small pancreas size predicts a faster progression to stage 3 Type 1 diabetes (T1D), the point at which clinical diagnosis occurs.

Read more

A biomarker for early Type 2 diabetes

Feb. 1, 2024—Genetic analyses suggest that branched chain amino acids may be a sensitive biomarker of early or subclinical Type 2 diabetes and could be used to identify risk and implement preventive measures.

Read more

Record year for the Vanderbilt Transplant Center saves 739 lives

Jan. 31, 2024—The Vanderbilt Transplant Center established a new record in calendar year 2023 for total solid organ transplants, performing 739 lifesaving procedures among its adult and pediatric organ transplant programs.

Read more

Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
VUMC Voice